Hawaii SCR 18: REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Status: The committee on HHS deferred the measure. (as of 2026-03-30)

State: Hawaii · Session: 2026 · Bill: SCR 18

Subjects: Auditor, Health, Insurance, Ketamine Therapy, Medicaid, Report

Sponsors: FEVELLA, KEOHOKALOLE

View Hawaii SCR 18 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.